23 May 2022

Marlowe plc

("Marlowe" or the "Company")

Exercise of Share Options under 2020 SAYE Scheme

Total Voting Rights

The Company announces that, as a result of an exercise of employee share options under the Marlowe 2020 SAYE Scheme, application has been made for 923 new ordinary shares of 50 pence each in the Company (the "New Ordinary Shares") to be admitted to trading on AIM.

The New Ordinary Shares will rank pari passu with the Company's existing ordinary shares and it is expected that admission will occur at 8.00 a.m. on 27 May 2022.

Following admission of the New Ordinary Shares, the Company's issued ordinary share capital will comprise 95,838,471 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Marlowe following admission will be 95,838,471.

For further information:

 About Marlowe plc

Marlowe is a UK leader in business-critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services. It is focused on compliance software, eLearning, health & safety, employment law and HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets and leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.